Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2004-04-07 / Am. J. Respir. Crit. Care Med. 2004 Jun;169(12):1322-30Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer
/in Hyperthermia, International Publications, Ovarian Cancer /von 2004-04-01 / Int. J. Clin. Oncol. 2004 Apr;9(2):85-91[Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)]
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2004-04-01 / Pneumologie 2004 Apr;58(4):210-6The role of idiotype vaccines in the treatment of human B-cell malignancies
/in International Publications, Malignant Lymphoma /von 2004-04-01 / Expert Rev Vaccines 2004 Apr;3(2):163-70
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution